Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
FDA Approves Seglentis for Acute Pain Management
October 21st 2021Celecoxib and tramadol hydrochloride (Seglentis; Esteve Pharmaceuticals) is an oral prescription with a unique co-crystal formulation of the anti-inflammatory drug, celecoxib, and the schedule IV opioid analgesic drug, tramadol.
Read More
Connection Between Pharmacists and Prescribers Can Support Mental Health
October 18th 2021Stacy Miller, senior content management consultant for Wolters Kluwer Health, discusses how mental health in the United States could be improved by stronger connections between prescribers and pharmacists.
Read More
The FDA Modernization Act of 2021 Aims to Use Alternatives to Animal Testing
October 15th 2021Aysha Akhtar, CEO and co-founder for the Center for Contemporary Sciences discusses the FDA Modernization Act of 2021, aiming to modernize the drug testing process by allowing the use of other testing methods as an alternative to animal testing.
Read More